WallStreetZenWallStreetZen

NASDAQ: ZYME
Zymeworks Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for ZYME

Based on 1 analyst offering 12 month price targets for Zymeworks Inc.
Min Forecast
$8.00-13.89%
Avg Forecast
$8.00-13.89%
Max Forecast
$8.00-13.89%

Should I buy or sell ZYME stock?

Based on 1 analyst offering ratings for Zymeworks Inc.
Hold
Strong Buy
0 analysts 0%
Buy
0 analysts 0%
Hold
1 analysts 100%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their ZYME stock forecasts and price targets.

ZYME stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2023-08-15

1 of 1

Forecast return on equity

Is ZYME forecast to generate an efficient return?
Company
N/A
Industry
-0.69%
Market
30.34%

Forecast return on assets

Is ZYME forecast to generate an efficient return on assets?
Company
N/A
Industry
-0.29%

ZYME revenue forecast

What is ZYME's revenue in the next 3 years based on estimates from 5 analysts?
Avg 1 year Forecast
$73.6M-84.06%
Avg 2 year Forecast
$113.4M-75.43%
Avg 3 year Forecast
$143.5M-68.91%
ZYME's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

ZYME revenue growth forecast

How is ZYME forecast to perform vs Biotechnology companies and vs the US market?
Company
-31.95%
Industry
34.65%
Market
7.68%
ZYME's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
ZYME's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

ZYME vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
ZYME$9.29$8.00-13.89%Hold
TVTX$8.64$18.00+108.33%Strong Buy
CNTA$6.65$10.00+50.38%Buy
AVXL$7.96$54.00+578.39%Buy
RVNC$7.37$24.75+235.82%Strong Buy
View Top Biotech Stocks

Zymeworks Stock Forecast FAQ

Is Zymeworks Stock a good buy in 2023, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: ZYME) stock is to Hold ZYME stock.

Out of 1 analyst, 0 (0%) are recommending ZYME as a Strong Buy, 0 (0%) are recommending ZYME as a Buy, 1 (100%) are recommending ZYME as a Hold, 0 (0%) are recommending ZYME as a Sell, and 0 (0%) are recommending ZYME as a Strong Sell.

If you're new to stock investing, here's how to buy Zymeworks stock.

What is ZYME's revenue growth forecast for 2023-2025?

(NASDAQ: ZYME) Zymeworks's forecast annual revenue growth rate of -31.95% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 34.65%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 7.68%.

Zymeworks's revenue in 2023 is $461,579,000.On average, 5 Wall Street analysts forecast ZYME's revenue for 2023 to be $5,151,306,219, with the lowest ZYME revenue forecast at $3,388,096,171, and the highest ZYME revenue forecast at $6,090,172,869. On average, 5 Wall Street analysts forecast ZYME's revenue for 2024 to be $7,937,945,318, with the lowest ZYME revenue forecast at $4,200,119,220, and the highest ZYME revenue forecast at $11,270,319,907.

In 2025, ZYME is forecast to generate $10,046,825,178 in revenue, with the lowest revenue forecast at $3,688,404,695 and the highest revenue forecast at $16,975,481,848.

What is ZYME's forecast return on assets (ROA) for 2023-2026?

(NASDAQ: ZYME) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of -0.29%.

What is ZYME's Price Target?

According to 1 Wall Street analyst that have issued a 1 year ZYME price target, the average ZYME price target is $8.00, with the highest ZYME stock price forecast at $8.00 and the lowest ZYME stock price forecast at $8.00.

The Wall Street analyst predicted that Zymeworks's share price could fall to $8.00 by Aug 15, 2024. The average Zymeworks stock price prediction forecasts a potential downside of 13.89% from the current ZYME share price of $9.29.

What is ZYME's forecast return on equity (ROE) for 2023-2026?

(NASDAQ: ZYME) forecast ROE is N/A, which is considered weak.
©2023 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.